PDS Biotech Achieves Safety Requirement Milestone For the First 12 Patients in the VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Advanced Head and Neck Cancer

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice